Pharma Execs rarely charged when laws are broken

In the huge profits raked in my Big Pharma is tons of money for law suits etc Its not a big deal and the way they do business

The United States’ Park doctrine allows CEOs and other executives at drug and medical device companies to be criminally charged when their company engages in illegal activities. This is meant to deter this sort of action. However, despite the ubiquitous billion-dollar fines that pharmaceutical companies have paid after engaging in illegal activity, executives are rarely charged.

According to a new study in JAMA Internal Medicine, only 13 cases of Park have been brought since the 2000s, three of which were executives of Purdue Pharma for their alleged role in creating the opioid crisis.

“Corporate officers do not generally bear personal criminal liability for illegal activities of the companies they run as long as their actions fall within the scope of their position,” the authors write.

The study was conducted by C. Joseph Ross Daval, JD, Jerry Avorn, MD, and Aaron S. Kesselheim, MD, JD, MPH. The researchers are all members of the Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, at Brigham and Women’s Hospital and Harvard Medical School in Boston.

Pharma Execs Rarely Charged When Their Companies Break the Law